Abstract
Phencyclidine (Sernyl, Phen) is a potent psychotomimetic drug in man. In conjunction with restraint stress, Phen produces increased plasma creatine phosphokinase (CPK) and aldolase (Ald) activities and skeletal muscle pathology in rats. Increased plasma CPK and Ald activities and skeletal muscle pathology are found in some acutely psychotic patients. It was therefore of interest to determine if Phen increased plasma CPK or Ald levels in man. Four of seven subjects had no elevations of plasma CPK or Ald activity either before or after Phen, 0.1 mg/kg, i.v. One subject had increased CPK levels which began 1 h after Phen. Two subjects had increased Ald and/or CPK levels which began within 24 h before Phen administration and which persisted or increased for at least 24 h after Phen. The plasma enzyme changes occurred in those subjects who showed the most pronounced cognitive disruption after Phen. The effects of stress and Phen on plasma CPK and Ald levels and its implications for the study of muscle abnormalities in psychotic patients are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahlborg, B., Brohult, J.: Metabolic changes after longterm physical exercise. Forsvarsmedicin 2, 35–49 (1966).
Bengzon, A., Hippius, H., Kanig, K.: Some changes in the serum during treatment with psychotropic drugs. J. nerv. ment. Dis. 143, 369–376 (1966).
Bennert, H. W., Betts, A.: The serum CPK levels in postoperative patients over forty. J. Maine med. Ass. 58, 214–218 (1967).
Bodi, T., Share, I., Levy, H., Moyer, J. H.: Clinical trial of phencyclidine (Sernyl) in patients with psychoneurosis. Antibiot. Med., Brit. Ed. 6, 79–84 (1959).
Coffey, J. W., Guschwan, A., Heath, R.: Serum creatine phosphokinase, aldolase, and copper in acute and chronic schizophrenics. Soc. Biol. Psychol. 2, 331–340 (1970).
Cohen, B. D., Luby, E. D., Rosenbaum, G., Gottlieb, J. S.: Combined Sernyl and sensory deprivation. Comp. Psychiat. 1, 345–348 (1960).
Davies, B. M.: A preliminary report on the use of sernyl in psychiatric illness. J. ment. Sci. 106, 1073–1079 (1960).
Fischman, D. A., Meltzer, H. Y., Poppei, R. W.: The disruption of myofibrils in the skeletal muscle of acutely psychotic patients. Arch. gen. Psychiat. 23, 503–515 (1970).
Griffiths, P. D.: Serum levels of ATP: Creatine phosphotransferase (creatine kinase), the normal range and effect of muscular activity. Clin. chim. Acta 13, 413–420 (1966).
Kupfer, D. J., Meltzer, H. Y., Wyatt, R. J., Snyder, F.: Serum enzyme changes in sleep deprivation. Nature (Lond.) 228, 768–770 (1970).
Laives, T.: Schizophrenia, “Sernyl” and sensory deprivation. Brit. J. Psychiat. 109, 243–250 (1963).
Luby, E. D., Cohen, B. D., Rosenbaum, G., Gottlieb, J. S., Kelley, R.: Study of a new schizophrenomimetic drug—Sernyl. Arch. Neurol. Psychiat. 81, 363–369 (1959).
Meltzer, H. Y., Muscle enzyme release in the acute psychoses. Arch. gen. Psychiat. 21, 102–112 (1969).
—, Plasma creatine phosphokinase activity, hypothermia and stress. Amer. J. Physiol. 221, 896–901 (1971a).
—, Factors influencing serum creatine phosphokinase levels in the general population. The role or race, activity and age. Clin. chim. Acta 33, 165–172 (1971b).
- Central core fibers in an acutely psychotic patient. Evidence for a neurogenic basis for the muscle abnormalities in the acute psychoses. Arch. gen. Psychiat. (in press) (1972a).
- Muscle toxicity produced by phencyclidine and restraint stress. Res. Comm. in Chem. Path. (in press) (1972b).
- Muscle abnormalities in the affective disorders. (Submitted for publication) (1972c).
—, Elkun, L., Moline, R.: Serum enzyme changes in newly admitted psychiatric patients. Arch. gen. Psychiat. 21, 731–738 (1969).
—, Engel, W. K.: Histochemical abnormalities of skeletal muscle in patients with acute psychoses. Part II. Arch. gen. Psychiat. 23, 492–502 (1970).
—, Moline, R.: Muscle abnormalities in acute psychoses. Arch. gen. Psychiat. 23, 481–491 (1970a).
— —: Plasma enzymatic activity after exercise: Study of psychiatric patients and their relatives. Arch. gen. Psychiat. 22, 390–339 (1970b).
—, Morzak, S., Boyer, M.: Effect of intramuscular injections on serum creatine phosphokinase activity. Amer. J. med. Sci. 259, 42–49 (1970).
—, Nankin, R., Raftery, J.: Serum creatine phosphokinase activity in newly admitted psychiatric patients. II. Arch. gen. Psychiat. 24, 568–572 (1971).
—, Pahnke, W., Kurland, A., Henkin, R.: Serum CPK and aldolase activity in man following psychotomimetic drugs. Psychopharmacologia (Berl.) 16, 419–425 (1970).
Pollard, J. C., Bakker, C., Uhr, L., Feuerfile, D. F.: Controlled sensory input: A note on the technic of drug evaluation with a preliminary report on a comparative study of Sernyl, Psilocybin and LSD-25. Comp. Psychiat. 1, 377–380 (1960).
Pyorala, K., Gordin, R., Konttinen, A., Telivrio, L.: Serum enzymes after cardiac surgery. Acta med. scand. 174, 361–374 (1963).
Rosenbaum, G. R., Cohen, B. D., Luby, E. D., Gottlieb, J. S., Yelen, D.: Comparison of Sernyl with other drugs. Arch. gen. Psychiat. 1, 651–656 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meltzer, H.Y., Holzman, P.S., Hassan, S.Z. et al. Effects of phencyclidine and stress on plasma creatine phosphokinase (CPK) and aldolase activities in man. Psychopharmacologia 26, 44–53 (1972). https://doi.org/10.1007/BF00421917
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00421917